Phase 1 Clinical Trial Met All Primary and Secondary Endpoints and Demonstrated Positive Safety, Pharmacokinetics, and ...

The global hernia repair devices market is projected to grow at a steady CAGR of approximately 5–7% through 2027. Market ...

Paraquat is banned in more than 70 countries, but still legal in the United States. Now, a growing number of U.S. farmers are ...

Memorial Sloan Kettering Cancer Center researchers continued to make strides against cancer in 2025. Learn about some of ...

A discovery in mice reveals why fasting enhances a type of breast cancer treatment — a hormone-signalling pathway and gene-expression changes have key roles. Stephen D. Hursting is in the Department ...

MIT engineers have quietly solved one of the biggest bottlenecks in living-tissue robotics, creating synthetic tendons that ...

The interaction between genetics and tissue environment shapes how individual teeth form in different regions of the jaw. While most experimental ...

A strange, contagious cancer is threatening Tasmanian devils, but researchers’ fight is fueling breakthroughs in science, ...

The ASX healthcare sector has logged another week in the red and, without a Christmas miracle, looks set to end 2025 as the ...

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...

Rivian Automotive, Inc. ( RIVN) Discusses AI-Centric Approach to Vehicle Autonomy and Technology Roadmap December 11, 2025 12:00 PM EST Please welcome RJ Scaringe, Founder and Chief Executive Officer ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the ...